Correlation Between Teva Pharma and Bausch Health
Can any of the company-specific risk be diversified away by investing in both Teva Pharma and Bausch Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teva Pharma and Bausch Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Teva Pharma Industries and Bausch Health Companies, you can compare the effects of market volatilities on Teva Pharma and Bausch Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teva Pharma with a short position of Bausch Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teva Pharma and Bausch Health.
Diversification Opportunities for Teva Pharma and Bausch Health
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Teva and Bausch is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharma Industries and Bausch Health Companies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bausch Health Companies and Teva Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teva Pharma Industries are associated (or correlated) with Bausch Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bausch Health Companies has no effect on the direction of Teva Pharma i.e., Teva Pharma and Bausch Health go up and down completely randomly.
Pair Corralation between Teva Pharma and Bausch Health
Given the investment horizon of 90 days Teva Pharma Industries is expected to under-perform the Bausch Health. But the stock apears to be less risky and, when comparing its historical volatility, Teva Pharma Industries is 1.02 times less risky than Bausch Health. The stock trades about -0.21 of its potential returns per unit of risk. The Bausch Health Companies is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest 773.00 in Bausch Health Companies on December 28, 2024 and sell it today you would lose (125.00) from holding Bausch Health Companies or give up 16.17% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Teva Pharma Industries vs. Bausch Health Companies
Performance |
Timeline |
Teva Pharma Industries |
Bausch Health Companies |
Teva Pharma and Bausch Health Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Teva Pharma and Bausch Health
The main advantage of trading using opposite Teva Pharma and Bausch Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teva Pharma position performs unexpectedly, Bausch Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will offset losses from the drop in Bausch Health's long position.Teva Pharma vs. Haleon plc | Teva Pharma vs. Bausch Health Companies | Teva Pharma vs. Zoetis Inc | Teva Pharma vs. Takeda Pharmaceutical Co |
Bausch Health vs. Viatris | Bausch Health vs. Tilray Inc | Bausch Health vs. Zoetis Inc | Bausch Health vs. Emergent Biosolutions |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |